Shimadzu denied infringing the patents, but it agreed to discontinue sales of the MultiNA system in the US.
The company has completed paying off a $600,000 settlement agreement for using Health Discovery Corporation's SVM IP for protein biomarker discovery.
The settlement will end a dispute dating back more than two years and likely help CombiMatrix as it continues to seek "strategic options" for the company.
The agreement to issue additional shares settles claims brought against Sequenom for alleged breach of representations and warranties made by Sequenom in its asset purchase agreement.
The settlement ends a one-year-old dispute regarding mass-spec based patents held by Sequenom.
The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.
According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.
New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.
In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.